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We used a regression model to examine the impact of
influenza on death rates in tropical Singapore for the
period 1996–2003. Influenza A (H3N2) was the predomi-
nant circulating influenza virus subtype, with consistently
significant and robust effect on mortality rates. Influenza
was associated with an annual death rate from all causes,
from underlying pneumonia and influenza, and from under-
lying circulatory and respiratory conditions of 14.8 (95%
confidence interval 9.8-19.8), 2.9 (1.0–5.0), and 11.9 (8.3–
15.7) per 100,000 person-years, respectively. These
results are comparable with observations in the United
States and subtropical Hong Kong. An estimated 6.5% of
underlying pneumonia and influenza deaths were attributa-
ble to influenza. The proportion of influenza-associated
deaths was 11.3 times higher in persons age >65 years
than in the general population. Our findings support the
need for influenza surveillance and annual influenza vacci-
nation for at-risk populations in tropical countries.
I
nfluenza virus infections cause excess illness and deaths
in temperate countries. In the Northern and Southern
Hemispheres, influenza epidemics occur nearly every win-
ter, leading to an increase in hospitalizations and deaths.
The World Health Organization (WHO) estimated that
these annual epidemics result in 3 to 5 million cases of
severe illness and 250,000–500,000 deaths each year
around the world (1). In the United States, influenza is
responsible for 50 million illnesses and up to 47,200
deaths annually (2–4).
However, little is known about the impact of influenza
on death rates in tropical regions, where the effect of
influenza is thought to be less (5). In subtropical Hong
Kong, deaths from underlying pneumonia and influenza
attributable to influenza were estimated to be 4.1/100,000
population per year (6),higher than the rate (3.1/100,000)
reported in the United States (7).
In tropical Singapore, influenza viruses circulate year
round, with a bimodal increase in influenza incidence
observed in April−July and November−January (8-13).
The peaks correspond approximately to increased influen-
za activities in temperate countries in the Southern and
Northern Hemispheres, respectively (14,15). Singapore is
geographically located in the tropics, lying just north of the
equator at latitude 1.5°N and longitude 104°E. Its climate
is characterized by uniform temperatures of minimum
23°C–26°C and maximum 31°C–34°C and a relative
humidity of 84% with maximum rainfall occurring in April
and December (16). These conditions are typical for most
tropical countries.
Any assessment of the true impact of influenza in the
tropics must account for the more diffused seasonal pattern
of influenza in the tropics and the cocirculation of other
respiratory viruses. Respiratory syncytial virus (RSV) is
also associated with excess deaths (17). Thus, the effect of
this virus would have to be adjusted for. In this study, we
used a regression model to examine the impact of influen-
za, by virus type and subtype, on deaths in a tropical coun-
try, while adjusting for potential confounding effects by
other cocirculating influenza virus subtypes and RSV.
Methods
National Influenza Viral Surveillance
Influenza virus surveillance is carried out throughout
the year and has been instituted in Singapore since 1973.
We obtained monthly data on influenza A and B viruses
and RSV from the WHO-designated National Influenza
Centre in Singapore from January 1996 to December 2003.
Specimens tested for influenza and RSV were obtained
from pediatric inpatients at KK Women’s and Children’s
Hospital, patients from Singapore General Hospital and
other public-sector hospitals, as well as from adult outpa-
tients with influenzalike symptoms treated at sentinel pri-
mary health clinics. Specimens were tested either with
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RSV was detected by immunofluorescence tests and
virus isolation. Influenza viruses were identified by direct
antigen detection with immunofluorescence techniques,
serologic tests with complement fixation, and virus isola-
tion. To isolate influenza viruses, respiratory specimens
were added to primary cynomolgus monkey kidney tissue
cultures, which were rolled at 33°C and observed daily for
cytopathic effects. If no effect was observed, the HeLa
tubes were passaged blind at weekly intervals, and monkey
kidney tissue cultures were tested for hemadsorption with
guinea pig erythrocytes. Specimens were discarded after 4
weeks if negative. Influenza virus isolates were subse-
quently confirmed by immunofluorescence and typed by
hemagglutination-inhibition tests using strain-specific
antisera provided by the WHO Collaborating Centre for
Influenza at the Centers for Disease Control and
Prevention, Atlanta, Georgia, USA.
The National Influenza Center provided aggregated
data for this study, i.e., monthly numbers of total respirato-
ry specimens tested for influenza virus, positive influenza
test results, and influenza virus isolates by subtype, as well
as monthly RSV data. As the study spanned 8 years, we
anticipated that positive results could be affected by
changes in the number of tests performed. Therefore, we
opted to use the monthly proportion of positive test results
for a specific virus (with the respective monthly number of
specimens tested for the specific virus as the denominator)
as our indicator variable for virus activity, instead of
monthly positive counts.
Mortality Data
National mortality data were obtained from the
Registry of Births and Deaths. Under the Registration of
Births and Deaths Act, all deaths occurring within
Singapore and its territorial waters are required to be reg-
istered within 3 days of the occurrence. Each death was
categorized according to the International Classification of
Diseases, 9th Revision (ICD-9) codes. In this study, death
records were aggregated according to month of death from
January 1996 through December 2003. Three death out-
comes were analyzed: underlying pneumonia and influen-
za (P&I) deaths (ICD-9: 480−487), underlying circulatory
and respiratory (C&R) deaths (ICD-9: 390−519), and all-
cause deaths (ICD-9: 000−999).
Statistical Methods
We first applied 6 negative binomial regression models
(18) to the monthly number of deaths and monthly propor-
tions of positive influenza virus and RSV tests, to examine
the relationships between mortality and the respiratory
viruses (namely, models 1−6). Details of the models are
shown in the Appendix. We then used the full model
(model 6) to obtain the relative risks (RR) of death (and
95% confidence interval [CI]) from influenza A, A
(H3N2), A(H1N1), and B viruses, as well as RSV, for each
of the 3 mortality categories (i.e., all-cause, underlying
P&I, and underlying C&R deaths). We also attempted to
estimate the excess number of deaths from the viruses.
Apart from accounting for possible overdispersion of
the data in the models, the models also adjusted for poten-
tial confounding factors, including the number of days in
each month, linear and squared term of time trend, season-
ality (3−4 pairs of sine and cosine terms, allowing for 3 to
4 cycles per year to capture the main seasonal variations
per year), temperature, and relative humidity. Linear and
squared terms of time trend were included to capture sec-
ular trends, including population growth, changes in com-
pleteness of ICD coding, and changes in diagnostic
methods. For each model, residuals were examined for dis-
cernible patterns and autocorrelation by means of residual
plots and partial autocorrelation function plots. Since the
unit of analysis was the calendar month, the lag effects of
influenza and other covariates were not necessarily taken
into account. 
We estimated the influenza-associated mortality frac-
tion by dividing the number of excess deaths (the differ-
ence between observed and expected deaths) by the
number of observed deaths, when the proportion of posi-
tive influenza results was set to 0 in model 6. The 95% CI
for each estimated fraction was obtained by using the boot-
strap resampling method with 1,000 bootstrap resamples
(19). The number of excess deaths attributable to influen-
za was then derived by multiplying the total number of
deaths in each mortality category by the respective influen-
za-associated mortality fraction (6,20). We also derived the
excess mortality rate per 100,000 person-years by dividing
the number of excess deaths during the study period by the
sum of the annual midyear population for the entire 8-year
period. All analyses were performed by using S-Plus 6.0
Professional Release 2 software (Insightful Corporation,
Seattle, WA, USA).
Results
From January 1996 to December 2003, 57,060 speci-
mens were tested for influenza virus, and 51,370 were test-
ed for RSV. The volume of tests performed was noticeably
lower in the first 2 years and in the last year of the study
(Table 1). There were 9,103 positive results for RSV and
3,829 positive results for influenza. The annual mean num-
ber of tests positive for influenza A was 5.8% (range
2.6%−9.5%) and for influenza B, 0.9% (range 0.4%−
1.6%). Annually, influenza A(H3N2) was the predominant
influenza virus subtype in circulation. During the study
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December 1998 to January 1999 (the predominant circu-
lating strain was A/Sydney/5/97), December 2000 to
January 2001 (A/Moscow/10/99), December 2002 to
January 2003 (A/Moscow/10/99), and October–November
2003 (A/Fujian/411/2002). Smaller peaks were noted in
April−July in 1996, 1997, 1998, and 2002, and from
September to November in 1999 and 2003.
During the 8-year period, an annual mean of 15,616
deaths (range 15,301−16,024) occurred in Singapore. An
average of 1,798 (range 1,545−2,340) underlying P&I
deaths and 8,237 (range 7,833−8,715) underlying C&R
deaths occurred each year (Table 2).
The Figure shows the temporal trends for death out-
comes as well as influenza virus and RSV activities. Peaks
in monthly influenza A viruses corresponded very well
with peaks in monthly all-cause deaths, underlying P&I
deaths, and underlying C&R deaths.
We tested the Spearman rank correlations between
influenza and RSV, and meteorologic variables. Influenza
A positivity (Spearman correlation [r] = 0.25) was weakly
correlated with relative humidity. However, temperature (r
= –0.71) was highly correlated with relative humidity. The
influenza A (H3N2) subtype had a high correlation with
influenza A (r = 0.75) (data not shown).
The relationship between deaths and each respiratory
virus (influenza A, influenza B, and RSV) was examined
by using a stepwise sequential approach (Table 3), i.e., first
fitting each of the viruses into separate models (models
1–3), then adjusting for 1 of the other 2 viruses (models 4,
5), and finally, adjusting for all viruses in a single model
(model 6). Furthermore, potential confounding factors
were adjusted for and included in each model.
Influenza A had significant and robust effects on
monthly all-cause deaths (RR 1.05 for each 10% change in
positive test results, without adjusting for influenza B
virus, RSV, and other potential confounding factors; vs.
RR 1.05, after adjusting for influenza B, RSV, and other
confounding factors), underlying P&I (RR 1.12 vs. RR
1.13), and underlying C&R (1.08 vs. 1.09) deaths.
In Table 4, we used model 6 (as described in Table 3) to
further explore the association between influenza A virus
subtypes and the 3 death outcomes. We replaced influenza
A variable with influenza A subtypes and adjusted for
influenza B virus, RSV, and other confounding factors.
Only influenza A (H3N2) had significant (all p values
<0.001) effects on all-cause deaths (RR 1.04 for each 10%
change in positive test results, 95% CI 1.02−1.05), under-
lying C&R deaths (1.05, 1.04−1.07), and underlying P&I
deaths (1.08, 1.04−1.12).
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C&R deaths (RR 1.01 for each 1% change in positive test
results, 95% CI 1.00−1.03, p = 0.037) and all-cause deaths
(1.01, 1.00−1.02, p = 0.008), but not on underlying P&I
deaths (p = 0.878). RSV had no observable impact on all 3
death categories analyzed (RR range 1.00−1.01 for each
10% change in positive test results, p>0.099) (Table 4).
Next, we used the full model to quantify the excess
deaths attributable to influenza throughout the year. For
deaths from all causes, we estimated an annual mean of
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Figure. Temporal trends in the positivity of
specific respiratory viruses (influenza A,
influenza B, and respiratory syncytial
virus [RSV]) and the number of all-cause
deaths (A), underlying pneumonia and
influenza (P&I) deaths (B), and underlying
circulatory and respiratory (C&R) deaths
(C), January 1996–December 2003;
+ve%, percent positive. 588 influenza-associated deaths (Table 5), representing
3.8% of total deaths. The mean annual estimates of deaths
from underlying P&I and C&R associated with influenza
were 116 and 475, respectively, representing 6.5% and
5.8% of such deaths.
We observed that the proportion of influenza-associat-
ed deaths was higher among the elderly. The annual
influenza-associated proportion of deaths from all causes
was 11.3 times higher in persons age >65 years
(167.8/100,000 person-years) than in the general popula-
tion (14.8/100,000). For influenza-associated underlying
P&I deaths, the annual death rate in those >65 years
(46.9/100,000) was 16.2 times higher than those in the
general population (2.9/100,000) (Table 5).
Table 6 compares the excess deaths observed in our
study with that derived from studies in a subtropical and
temperate country (6,7). While we observed a smaller
overall impact for all ages than that reported in Hong Kong
(6) and the United States (7), we noted a higher proportion
of influenza-associated deaths among the elderly in
Singapore.
Discussion
To our knowledge, our findings are the first to demon-
strate that influenza activity is associated with excess
deaths in a tropical country. Our estimates of annual
influenza-associated all-cause deaths, underlying P&I
deaths, and underlying C&R deaths in Singapore were
14.8, 2.9, and 11.9 per 100,000 person-years, respectively.
This finding would translate to an estimated 588 deaths
(3.8% of total deaths) due to influenza annually, which is
comparable to the proportion of deaths observed in sub-
tropical Hong Kong (6) and in the United States (7), a tem-
perate country. 
Our estimate of 46.9 underlying P&I deaths per
100,000 persons age >65 years each year is lower than the
estimate of a local study (21). However, that study
acknowledged a possible overestimation of the incidence
of influenza in the elderly. Moreover, their estimates were
based on the assumption that 40% of P&I deaths were
associated with influenza, which was a figure derived from
external data from temperate countries. This figure far
exceeds our estimate of 6.5% of underlying P&I deaths
attributable to influenza. In Hong Kong (6) and the United
States (7), influenza-associated deaths represented 7.4%
and 9.8% of underlying P&I deaths, respectively. 
In Singapore, we observed that the influenza-associated
proportion of deaths was highest in persons >65 years.
Again, this finding is consistent with those in the United
States where 90% of influenza-associated deaths occurred
among the elderly (7). In this population, we estimated an
annual number of excess deaths per 100,000 population of
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P&I, and 155.4 deaths from underlying C&R attributable
to influenza.
In fact, our estimates for influenza-associated deaths in
persons age >65 years were consistently higher than those
in Hong Kong and United States, for all 3 mortality out-
comes. A possible reason could be the use of influenza
vaccines among vulnerable elderly is higher in the United
States and Hong Kong than in Singapore. Influenza vacci-
nation for all persons age >65 years is a well-established
recommendation of the Advisory Committee on
Immunization Practice (ACIP) in the United States (22).
Vaccine coverage among elderly persons (>65 years) in the
United States increased from 15% to 20% before 1980 to
65% in 2001 (23), and the national target of 60% coverage
in this population has been achieved since 1997 (24). In
Hong Kong, the use of vaccine has been limited (25).
However, the vaccine has been recommended for institu-
tionalized elderly since 1997, and the Department of
Health has had a program to vaccinate this population
since 1998 (26). In Singapore, influenza vaccine use has
been low, and the mean annual quantity used in 2001–2002
was only ≈20,000 doses (Ministry of Health, Singapore,
unpub. data). The number of persons age >65 averaged
≈250,000 during that period (27). Even if all 20,000 vac-
cine doses had been given to this group of persons, vacci-
nation coverage in the elderly would not have exceeded
8% per year. 
Annual influenza vaccination for persons age >65 years
has been recommended since September 2003 in
Singapore by the National Expert Committee on
Immunization. Influenza vaccine efficacy for preventing
death among people >65 years was estimated to be 68%
(28). In a recent study, vaccine effectiveness in those >75
years of age was found to be even greater (29). However,
such studies have yet to be conducted in the tropics. We
recommend a follow-up study to estimate the impact of
vaccination on influenza-associated deaths in this age
group in Singapore. 
With regard to influenza subtypes, we note that most
seasons in the United States were dominated by influenza
A (H3N2) virus (30); the greatest number of influenza-
associated deaths were associated with influenza A
(H3N2), followed by RSV, influenza B, and influenza A
(H1N1) virus (31). Influenza A (H3N2) virus accounted
for 60% and 77% of positive influenza isolates in the
United States (7) and Hong Kong (6), respectively. Our
findings were similar. Influenza A (H3N2) was the pre-
dominant virus subtype during our study period and had a
consistently significant impact on all 3 categories of
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effects on all-cause deaths and underlying C&R deaths, the
magnitudes of RRs were relatively small (RR 1.00−1.01,
for each 1% change in positive test results). In addition,
influenza B virus did not have any significant and observ-
able impact on underlying P&I deaths. We did not observe
any significant impact from influenza A (H1N1) virus and
RSV on all 3 outcomes.
One limitation of our study may have been that the
effect of RSV could have been obscured when we ana-
lyzed data on all ages. This virus is known to predominate-
ly affect children <2 years of age (8–10), <5% of the
population. However, this factor does not negate the main
finding that influenza infections are associated with sub-
stantial disease in Singapore. 
Studies suggest that global interhemispheric circulation
of epidemics follows an irregular pathway with recurrent
changes in the leading hemisphere (32). As a major travel
hub with a high volume of travelers from both hemi-
spheres, Singapore could be a sentinel for detecting
changes in the circulating virus strain and contribute
toward an understanding of influenza virus circulation
pathways. The prevalence of influenza in Singapore illus-
trates the importance of improving worldwide coverage
and quality of virologic and epidemiologic surveillance for
influenza, as described in WHO’s Global Agenda for
Influenza Surveillance and Control (33). 
Our findings have a few policy implications. First, they
support the recent recommendation by the National Expert
Committee on Immunization on annual influenza vaccina-
tion for elderly Singaporeans and for persons at high risk
of having complications from influenza. Second, the find-
ing that influenza infections account for substantial disease
supports our continued investment in strengthening
influenza surveillance in our country. Finally, the study
provides justification for stockpiling antiviral drugs in our
national influenza pandemic preparedness plan. An
influenza pandemic can be expected to result in far higher
attack and death rates (34,35) than currently observed. The
extent of disease and economic impact caused by an
influenza pandemic could be greatly reduced by the appro-
priate use of vaccines and antiviral drugs (36). 
Conclusion
In 2003, a new infectious disease, severe acute respira-
tory syndrome (SARS), emerged, which caused 238 cases
and 33 deaths in Singapore (37). The SARS outbreak gal-
vanized public health actions in surveillance and control.
Surveillance and plans for containing a resurgence of
SARS remain in place, in spite of the low risk of a recur-
rence. Influenza, in contrast, has caused an average of 588
excess deaths in Singapore annually. Influenza continues
to cause an increasing amount of disease in Singapore, par-
ticularly in our rapidly aging population. However, avail-
able strategies in influenza prevention and control have yet
to be optimized, largely because the true impact of influen-
za has been masked by the lack of a clear seasonal pattern
in the tropics. The extent of the infection has remained
largely unseen. 
Our study is the first to show unequivocally that
influenza has a significant impact on proportion of deaths
in a tropical country like Singapore. The estimated excess
deaths, while less than that observed in subtropical and
temperate countries, still constitutes a substantial problem.
As influenza-associated deaths are largely preventable
through vaccination and the judicious use of antiviral
drugs, our findings can influence the public health man-
agement of this disease. 
Dr Chow is a public health physician and currently oversees
the Communicable Diseases Surveillance Branch at Singapore’s
Ministry of Health. Her research interests include infectious dis-
ease epidemiology and public health surveillance.
Appendix
We developed 6 negative binomial regression models to
examine the relationships between proportion of deaths and the
respiratory viruses, namely, influenza A virus, influenza B virus,
and respiratory syncytial virus (RSV) (Table 3). The models were
written as follows:
Model 1
Monthly number of deaths = monthly proportion of influenza
A + number of days in each month + linear time trend + squared
time trend + 3–4 pairs of seasonality variables + monthly mean
temperature + monthly mean relative humidity
Model 2
Monthly number of deaths = monthly proportion of influenza
B + number of days in each month + linear time trend + squared
time trend + 3–4 pairs of seasonality variables + monthly mean
temperature + monthly mean relative humidity
Model 3
Monthly number of deaths = monthly proportion of RSV +
number of days in each month + linear time trend + squared time
trend + 3–4 pairs of seasonality variables + monthly mean tem-
perature + monthly mean relative humidity
Model 4 
Monthly number of deaths = monthly proportion of influenza
A + monthly proportion of influenza B + number of days in each
month + linear time trend + squared time trend + 3–4 pairs of sea-
sonality variables + monthly mean temperature + monthly mean
relative humidity
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Monthly number of deaths = monthly proportion of Influenza
A+ monthly proportion of RSV + number of days in each month
+ linear time trend + squared time trend + 3-4 pairs of seasonal-
ity variables + monthly mean temperature + monthly mean rela-
tive humidity
Model 6 
Monthly number of deaths = monthly proportion of influenza
A + monthly proportion of influenza B + monthly proportion of
RSV + number of days in each month + linear time trend    +
squared time trend + 3-4 pairs of seasonality variables + month-
ly mean temperature + monthly mean relative humidity
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